BuzzRx® Unveils Insights From New “State of Our Health” Data Report

In-Depth Exploration of Five Key Topics for October’s Awareness Month Themes

FORT LAUDERDALE, Fla., Oct. 9, 2024 /PRNewswire/ — BuzzRx, a free prescription savings service that allows customers to instantly find the lowest price on their medication at pharmacies nationwide, unveils its latest report, “State of Our Health,” which offers valuable insights aligned with October’s Awareness Month themes. This comprehensive analysis covers five key categories, reflecting vital topics relevant this month:

  • The State of Mental Health
  • The State of Menopause
  • The State of ADHD
  • The State of Breast Cancer
  • The State of Bone Health

BuzzRx conducted an in-depth analysis of national prescription medication usage from January 1, 2023, to August 1, 2024, aiming to uncover trends, demographic insights, and the popularity of specific treatments for each topic.

Key insights include:

  • Nationally, females aged 30 – 39 fill the most mental health prescriptions.
  • BuzzRx customers searched for and filled menopause-related medications that contained estradiol (in various forms and doses) more than any other treatment.
  • Dextroamphetamine-amphetamine (Adderall) is the most filled medication to help treat ADHD in all fifty states.
  • Chemotherapy medications had the highest number of prescriptions filled nationally, while hormonal (endocrine) therapy had the highest potential for cost savings.
  • Alendronate dominated prescriptions filled nationwide for bone health, even compared with other bisphosphonates.

“We’re proud to release our new ‘State of Our Health’ report, which delves into trends in prescription data and highlights key issues relevant to October,” says Matthew Herfield, Co-Founder and CEO of BuzzRx. “At BuzzRx, our mission is to empower patients by identifying significant opportunities for saving on medications while educating them about the evolving landscape of the pharmaceutical industry.”

Medication trends evolve each year as new drugs emerge and consumer preferences shift. With the overall cost of healthcare in the U.S. projected to rise, BuzzRx is committed to transforming industry trends and actionable insights into tangible savings for consumers.

Anyone can use BuzzRx, whether insured or uninsured. Customers have saved an annual average of nearly $850 when filling at least one prescription monthly. BuzzRx discounts can save customers up to 80% off medications and are accepted at over 60,000 pharmacies nationwide. Visit BuzzRx.com or download the free BuzzRx app to search for local prescription savings by zip code, and present the coupon at your preferred pharmacy when filling or refilling a prescription.

For more information and to read the full report, please visit www.BuzzRx.com.

About BuzzRx
BuzzRx is a free prescription discount service that allows users to find the lowest price on their medication instantly at over 60,000 pharmacies nationwide. The website and free mobile app promote drug transparency by allowing users to compare discounted prices across pharmacy chains, helping reduce out-of-pocket costs and sticker shock at the counter. Since 2021, BuzzRx has helped over 10 million people in the U.S. save up to 80% on their medications, resulting in over $1.5 billion saved. BuzzRx also supports its nonprofit partners year-round, donating over $9.5 million. For more information, visit BuzzRx.com or download the app on iOS and Android.

Press Contact
Press@BuzzRx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/buzzrx-unveils-insights-from-new-state-of-our-health-data-report-302270805.html

SOURCE BuzzRx

Staff

Recent Posts

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

6 minutes ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

6 minutes ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

6 minutes ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

3 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

9 hours ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

15 hours ago